Driving more WHO-recommended vaccines in the National Immunization Program: Issues and challenges in China
- PMID: 37099400
- PMCID: PMC10158540
- DOI: 10.1080/21645515.2023.2194190
Driving more WHO-recommended vaccines in the National Immunization Program: Issues and challenges in China
Abstract
WHO-recommended vaccines substantially prevent and control vaccine-preventable diseases (VPDs), but their inclusion differs among countries and regions. We reviewed the application for WHO-recommended vaccines in China and described the concerns and obstacles in driving the inclusion of more vaccines into China's NIP, including immunization strategies, financial barriers, vaccination services, and behavioral and social supply-side and demand-side factors. China has made significant efforts, however, they may not be sufficient until the inclusion of more WHO-recommended vaccines in the National Immunization Program (NIP), ensuring that the vaccination encompasses the whole life course of individuals, establishment of more trustworthy vaccination finance and procurement, increasing vaccine development, optimizing vaccine demand forecasts, improving the accessibility and equity of vaccination services, capturing the key points of behavioral and social drivers of vaccination on the demand side, and establishing holistic prevention and control from a public health perspective.
Keywords: National Immunization Program; disease; vaccine-preventable diseases; vaccines.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Similar articles
-
The equity road ahead for financing non-national immunization program vaccines in China: challenges and opportunities from a qualitative study.Int J Equity Health. 2024 Sep 27;23(1):193. doi: 10.1186/s12939-024-02282-5. Int J Equity Health. 2024. PMID: 39334358 Free PMC article.
-
Advancing the National Immunization Program in an era of achieving universal vaccine coverage in China and beyond.Infect Dis Poverty. 2024 Mar 13;13(1):25. doi: 10.1186/s40249-024-01192-6. Infect Dis Poverty. 2024. PMID: 38475849 Free PMC article.
-
The coverage and challenges of increasing uptake of non-National Immunization Program vaccines in China: a scoping review.Infect Dis Poverty. 2023 Dec 8;12(1):114. doi: 10.1186/s40249-023-01150-8. Infect Dis Poverty. 2023. PMID: 38062480 Free PMC article.
-
Developing an effective and sustainable national immunisation programme in China: issues and challenges.Lancet Public Health. 2022 Dec;7(12):e1064-e1072. doi: 10.1016/S2468-2667(22)00171-2. Epub 2022 Oct 15. Lancet Public Health. 2022. PMID: 36252582 Free PMC article. Review.
-
Public Preference and Priorities for Including Vaccines in China's National Immunization Program: Discrete Choice Experiment.JMIR Public Health Surveill. 2024 Nov 14;10:e57798. doi: 10.2196/57798. JMIR Public Health Surveill. 2024. PMID: 39588749 Free PMC article.
Cited by
-
Respiratory pathogenic microbial infections: a narrative review.Int J Med Sci. 2024 Mar 17;21(5):826-836. doi: 10.7150/ijms.93628. eCollection 2024. Int J Med Sci. 2024. PMID: 38617014 Free PMC article. Review.
-
Accelerating into Immunization Agenda 2030 with momentum from China's successful COVID-19 vaccination campaign during dynamic COVID Zero.Infect Dis Poverty. 2023 Oct 16;12(1):96. doi: 10.1186/s40249-023-01151-7. Infect Dis Poverty. 2023. PMID: 37845759 Free PMC article.
-
The equity road ahead for financing non-national immunization program vaccines in China: challenges and opportunities from a qualitative study.Int J Equity Health. 2024 Sep 27;23(1):193. doi: 10.1186/s12939-024-02282-5. Int J Equity Health. 2024. PMID: 39334358 Free PMC article.
-
Surveillance for adverse events following immunization with DTaP-containing combination vaccines in Linping, China, 2019-2022.Front Public Health. 2024 Mar 26;12:1278513. doi: 10.3389/fpubh.2024.1278513. eCollection 2024. Front Public Health. 2024. PMID: 38596516 Free PMC article.
-
Financing the introduction of new vaccines to the national immunisation programme in China: challenges and options for action.BMJ Glob Health. 2025 Mar 24;10(3):e017970. doi: 10.1136/bmjgh-2024-017970. BMJ Glob Health. 2025. PMID: 40127943 Free PMC article. Review.
References
-
- World Health Assembly (27th: 1974) . The expanded programme on immunization: the 1974 resolution by the world health assembly. Assignment Child. 1985;69-72:87–8. PMID: 12280461. - PubMed
-
- The National People’s Congress of the People’s Republic of China . Vaccine administration law of the People’s Republic of China. [accessed 2022 Apr 22]. http://www.npc.gov.cn/npc/c30834/201907/11447c85e05840b9b12c62b5b645fe9d.... (in Chinese).
-
- Japan Health Policy Now . Routine and voluntary immunization. [accessed 2022 May 25]. https://japanhpn.org/en/vaccinations-2/.
-
- GOV.UK . Historical vaccine development and introduction of vaccines in the UK. [accessed 2022 May 25]. https://www.gov.uk/government/publications/vaccination-timeline.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical